RHAZINILAM

ID: ALA302501

Max Phase: Preclinical

Molecular Formula: C19H22N2O

Molecular Weight: 294.40

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Rhazinilam
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CC[C@]12CCCn3ccc(c31)-c1ccccc1NC(=O)CC2

    Standard InChI:  InChI=1S/C19H22N2O/c1-2-19-10-5-12-21-13-9-15(18(19)21)14-6-3-4-7-16(14)20-17(22)8-11-19/h3-4,6-7,9,13H,2,5,8,10-12H2,1H3,(H,20,22)/t19-/m1/s1

    Standard InChI Key:  VLQAFTDOIRUYSZ-LJQANCHMSA-N

    Associated Targets(Human)

    KB (17409 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    A549 (127892 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    HT-29 (80576 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    T-cell line (174 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    PBMC (10003 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 294.40Molecular Weight (Monoisotopic): 294.1732AlogP: 4.33#Rotatable Bonds: 1
    Polar Surface Area: 34.03Molecular Species: NEUTRALHBA: 2HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 13.43CX Basic pKa: CX LogP: 3.83CX LogD: 3.83
    Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.83Np Likeness Score: 0.76

    References

    1. David B, Sevenet T, Thoison O, Awang K, Pais M, Wright M, Guenard D.  (1997)  Hemisynthesis of rhazinilam analogues: structure - activity relationships on tubulin-microtubule system,  (17): [10.1016/S0960-894X(97)00391-0]
    2. David B, Sevenet T, Thoison O, Awang K, Pais M, Wright M, Guenard D.  (1997)  Hemisynthesis of rhazinilam analogues: structure - activity relationships on tubulin-microtubule system,  (17): [10.1016/S0960-894X(97)00391-0]
    3. Subramaniam G, Hiraku O, Hayashi M, Koyano T, Komiyama K, Kam TS..  (2007)  Biologically active aspidofractinine, rhazinilam, akuammiline, and vincorine alkaloids from Kopsia.,  70  (11): [PMID:17939738] [10.1021/np0703747]
    4. Wu Y, Suehiro M, Kitajima M, Matsuzaki T, Hashimoto S, Nagaoka M, Zhang R, Takayama H..  (2009)  Rhazinilam and quebrachamine derivatives from Yunnan Kopsia arborea.,  72  (2): [PMID:19133778] [10.1021/np800489e]
    5. Zeng T, Wu XY, Yang SX, Lai WC, Shi SD, Zou Q, Liu Y, Li LM..  (2017)  Monoterpenoid Indole Alkaloids from Kopsia officinalis and the Immunosuppressive Activity of Rhazinilam.,  80  (4): [PMID:28218521] [10.1021/acs.jnatprod.6b00697]

    Source